These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Optimal utilization of Rh immunoglobulin in induced abortion.
    Author: Judelsohn RG, Townsend MK, Branch BN.
    Journal: Obstet Gynecol; 1973 Dec; 42(6):827-30. PubMed ID: 4202169.
    Abstract:
    A study which was designed to characterize and refine methods of identifying, educating, and treating Rh-negative women while monitoring Rh immunoglobulin use in an active abortion service is described. A simple system for the rapid analysis of Rh immunoglobulin use was developed. During a 7-week period, 255 of 265 Rh-negative unimmunized women received Rh immunoglobulin. 9 of the 10 women refusing it were older multiparas. Previous surveys have shown the utilization rates ranging from 42% to 68%. The 96.2% acceptance shown in this study is believed to demonstrate that optimal utilization can be approached with the appropriate procedures. At PRETERM, an out-patient abortion service in Washington, D.C., where this study took place, all women requesting abortion are tested for Rh type by the routine slide method. Serum from each specimen found to be Rh-negative is then tested for the presence of Rh antibody. Results from Rh-negative women are hand carried from the laboratory to the medical area, where the lab results and a vial of Rh immunoglobulin are attached to the patient's chart. The medical receptionist informs the counselor of the patient's blood type before the abortion. The woman and her counselor discuss the implications of Rh-negative blood type and abortion and the use of Rh immunoglobulin. An attempt is made to convince all women of the need for Rh immunoglobulin, regardless of their future child-bearing plans. Immediately after the abortion, with the patient's consent, a nurse administers the Rh immunoglobulin. All used and unused vials are returned to the laboratory. An Rh-negative identification card is given to the patient. There is no additional charge for Rh testing or Rh immunoglobulin. The authors believe that with the increasing incidence of induced abortion, such procedures are vital if Rh immunization and Rh hemolytic disease of the newborn are to be prevented.
    [Abstract] [Full Text] [Related] [New Search]